National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.8)
Instrument number PB 51 of 2011
National Health Act 1953
I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated               26                  July 2011
 
 
 
 
 
 
 
 
 
FELICITY MCNEILL
 
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.8).
         (2)   This Determination may also be cited as PB 51 of 2011.
2              Commencement
                This Determination commences on 1 August 2011.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
[1]     Schedule 1, after item dealing with Disopyramide
                  
Omit
 
          Dolasetron
 
[2]     Schedule 1, after item dealing with Everolimus
                  
Omit
 
          Exemestane
 
[3]     Schedule 1, after item dealing with Fenofibrate
                  
Omit
 
          Fentanyl
 
 
[4]     Schedule 2, after item dealing with Etoposide
                  
Insert
 
          Exemestane
 
[5]     Schedule 2, after item dealing with Felodipine
                  
Insert
 
          Fentanyl
 
 
 
 
Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.